Skip to main content

Table 1 Baseline characteristics of the patients grouped according to the IFNβ formulation

From: Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study

Characteristics

Avonex

n = 12

Rebif 22

n = 48

Rebif 44

n = 45

Betaferon

n = 36

p

Age (years)

39.9 ± 10.8

(27-64)

38.7 ± 9.1

(23-58)

35 ± 8.4

(21-58)

42.6 ± 10.1

(25-67)

0.04

Disease duration (years)

12.3 ± 6.6

(5-24)

9.9 ± 5.3

(2-24)

9.7 ± 5.4

(3-28)

13.6 ± 6.8

(3-34)

0.01

Therapy duration (years)

4.7 ± 1.7

(2-8)

4.2 ± 1.6

(1-9)

3.2 ± 1.8

(1-10)

5.7 ± 2.5

(1-10)

0.001

EDSS score

1.8 ± 1.0

(1-4.5)

1.9 ± 1.0

(0-5)

2.0 ± 1.2

(0-5.5)

2.65 ± 1.5

(0-6)

0.02

  1. All values are mean ± SD (range)